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Edited by Varda RotterAbstract Adenovirus early region 1B-associated protein 5,
E1B-AP5, a member of the heterogeneous nuclear ribonucleo-
protein (hnRNP) family, was originally isolated on the basis of
its ability to bind to the adenovirus 5 early region1B55K protein.
Here, it has been demonstrated that E1B-AP5 interacts with mu-
tant and wild-type p53 from human cells in pull-down assays
using GST-E1B-AP5. This interaction has been conﬁrmed by
co-immunoprecipitation studies and pull-down experiments with
in vitro translated E1B-AP5 and GST-p53. The binding site
for E1B-AP5 has been mapped to the C-terminal region of
p53. In reciprocal experiments, it has been shown that several re-
gions of E1B-AP5 bound to p53 although it is probable that a
major site of interaction is located between amino acids 395
and 732 of E1B-AP5. In reporter assays, E1B-AP5 inhibited
p53 transcriptional activity although not as eﬃciently as the
Ad5E1B55K protein. Transfection of E1B-AP5 into human tu-
mour cells aﬀected the cellular response to UV radiation, such
that, although p53 expression was induced, little change in the
level of p53-inducible genes could be observed.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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protein1. Introduction
Adenovirus early region 1B-associated protein 5 (E1B-AP5)
is a recently characterized member of the hnRNP family with
appreciable homology to hnRNP-U/SAF-A and to SAF-B. It
was ﬁrst isolated from a human expression library as a binding
partner for Ad5E1B55K protein [1]. It can bind to mRNA and
is involved in RNA transport and processing [1]. E1B-AP5
binds to the N terminal domain of TAP, a protein intimately
involved in RNA export from the nucleus [2]. During adenovi-
rus infection it is likely that a complex of AdE1B55K and
E1B-AP5 is, at least partially, responsible for the selective
accumulation of late viral mRNAs at the expense of host cell
transcripts [1].
Generally hnRNPs are involved in pre-mRNA processing,
nucleocytoplasmic mRNA transport, in mRNA localization,
translation and stability (reviewed for example [3]). They also
have a role in telomere length maintenance. Recent evidence*Corresponding author.
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doi:10.1016/j.febslet.2005.03.095has suggested the involvement of a variety of hnRNPs in tran-
scriptional regulation. For example, hnRNP-U/SAF-A can
regulate RNA polymerase II-dependent transcription by bind-
ing to TFIIH kinase and inhibiting phosphorylation of the pol
II C-terminal domain [4]. In addition, hnRNP SAF-B can bind
to the oestrogen receptor (ER) and act as a co-repressor such
that overexpression of SAF-B inhibits ER activity [5]. Simi-
larly, hnRNP-U/SAF-A interacts with the glucocorticoid
receptor and is able to regulate its activity [6]. Furthermore,
hnRNP-U/SAF-A interacts with p300 [7]. Binding of p300
and hnRNP-U/SAF-A to matrix-associated regions of DNA
is accompanied by local acetylation of nucleosomes. It has
been suggested that these interactions might immediately pre-
cede transcription of the relevant genes [7].
p53 is the most commonly mutated gene in human cancers.
Its primary function is in the response to DNA damage when
increased expression of the protein causes cell cycle arrest or
apoptosis. A number of p53 binding proteins have been iso-
lated including the products of small DNA tumour viruses
such as SV40T and AdE1B55K [8,9], the E3 ligase Mdm2
[10], CBP/p300 [11,12] and PML3 [13].
In the study presented here we have shown a direct associa-
tion between E1B-AP5 and p53. Binding sites on the two pro-
teins have been mapped. In addition, it has been demonstrated
that E1B-AP5 inhibits p53 transcriptional activity in reporter
assays, and inhibits induction of p53 regulated genes following
UV irradiation suggesting that it could play a part in the reg-
ulation of p53 activity in vivo.2. Materials and methods
2.1. Cell lines
A variety of human tumour cell lines and adenovirus early region
1-transformed lines were used in this study. HCT116 and HT29 are
human colon adenocarcinoma cell lines, A549 cells derive from a
human small cell lung carcinoma, C33A from a HPV negative cer-
vical carcinoma and MCF7 cells from a breast tumour. The H1299
cell line is from a non-small cell lung carcinoma. Ad5E1HER911
cells and Ad5E1HEK293 cells are human embryo retinoblasts and
human embryo kidney cells, respectively, transformed with the
Ad5 early region 1 DNA. Ad12E1HER2 cells are human embryo
retinoblasts transformed with the Ad12 E1 region. Cos cells are
monkey kidney cells, transformed with SV40T antigen. All cells were
maintained in Dulbeccos modiﬁed Eagles medium (DMEM) sup-
plemented with HEPES, 8% foetal calf serum (FCS) and 2 mM glu-
tamine. All cells express wt p53 with the exception of C33A and
HT29 which express the mutant protein at high level and H1299
which do not express p53 at all. The virally transformed cell lines
express wt p53 at high level, although it is largely transcriptionally
inactive.blished by Elsevier B.V. All rights reserved.
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Full-length human E1B-AP5 and p53 were cloned into pGEX. These
proteins were expressed as GST-fusions in Escherichia coli and puriﬁed
by aﬃnity chromatography using glutathione–agarose (Sigma). In
addition various polypeptide fragments of human p53 were expressed
as GST fusion proteins and puriﬁed as described below.
E1B-AP5, cloned into pcDNA3, was used for expression in in vitro
transcription–translation mix following the manufacturers instruc-
tions using wheat germ extract (Promega). Further polypeptides com-
prising amino acids 1–453, 213–732 and 400–856 of E1B-AP5 were
also expressed in vitro. These constructs, together with p53 cloned into
pcDNA3, were transfected into H1299 cells in the reporter assays.
2.3. Expression and puriﬁcation of GST fusion proteins
E1B-AP5 and p53, together with polypeptide fragments of p53, were
cloned into pGEX and expressed in E. coli BL21. After induction of
protein expression bacteria were collected by centrifugation and resus-
pended in PBS, 5 mM EDTA, 1% Triton X-100 (buﬀer A) at 4 C. The
suspension was sonicated (2 · 30 s) and centrifuged at 20000 · g for
30 min to remove insoluble material. Supernatants were incubated
for 1 h with glutathione–agarose (Sigma) on a rotator at 4 C. The aga-
rose beads were collected by centrifugation, washed three times with
buﬀer A and once with PBS, 1 mM EDTA. GST fusion proteins were
released by incubation for 1 h with 25 mM glutathione, pH 7.8. Puri-
ﬁed protein was dialysed against 0.1 M NaCl, 20 mM Tris, pH 7.2,
1 mM DTT and stored at 70 until required.
2.4. GST-pull-downs, immunoprecipitation and Western blotting
GST pull-down assays: two procedures were used. First, cells were
lysed by sonication in buﬀer A and clariﬁed by centrifugation
(35000 rpm for 30 min). Lysates were incubated with GST-E1B-AP5
(20 lg) on ice for 1 h and then with glutathione–agarose beads
(70 ll) for a further h with agitation. After extensive washing bound
proteins were eluted with 25 mM glutathione (pH 7.8) and subjected
to SDS–PAGE, and Western blotting. Second, 35S labelled methionine
in vitro translated protein (5 ll) was incubated with GST fusion pro-
tein (20 lg) in buﬀer A (300 ll) on ice for 1 h. Glutathione–agarose
beads (70 ll) were added and agitated for 1 h. After extensive washing
with buﬀer A bound proteins were released with 25 mM glutathione
(pH 7.8), and fractionated by SDS–PAGE. 35S labelled proteins were
identiﬁed by ﬂuorography and autoradiography.
For immunoprecipitation experiments, cells were washed with ice-
cold saline, dislodged from the culture dishes by scraping and har-
vested by centrifugation. Cells were lysed in 0.83 M NaCl, 20 mM
Tris–HCl, pH 7.2, 1% NP40. Volumes of lysate containing 3 mg pro-
tein were clariﬁed by centrifugation and incubated with appropriate
antibodies. Antigen–antibody complexes were isolated on protein
G–agarose beads (Sigma). After extensive washing, bound proteins
were released with SDS–PAGE sample buﬀer and fractionated by
SDS–PAGE. After electrophoretic transfer to nitrocellulose mem-
branes, antigens were identiﬁed by Western blotting using appropriate
antibodies and visualized with ECL reagent (Amersham).
2.5. Reporter assays
The eﬀect of E1B-AP5 on p53 activity was determined using a Dual-
Luciferase reporter assay system (Promega). H1299 cells were grown to
80–90% conﬂuency in 6-well plates. Cells were transfected with ﬁreﬂy
and Renilla luciferase expression vectors (Promega) (with the ﬁreﬂy
luciferase gene down-stream of ﬁve copies of a consensus p53 DNA
binding motif or the promoter of the p21 gene containing a single
p53 binding motif) using Lipofectamine 2000 according to the manu-
facturers instructions (Invitrogen). In addition, transfection of p53
with either full-length E1B-AP5, fragments of E1B-AP5 or
Ad5E1B55K was performed. After 24 h cells were harvested, lysed
and the luciferase activity measured using a luminometer. Eﬃciency
of transfection was calculated, based on the luminescence of a control
Renilla luciferase reporter, allowing results to be standardized.Fig. 1. E1B-AP5 and p53 expression. Cells were harvested, solubilized
and analysed by Western blotting for expression of: (A) E1B-AP5;
(B, C) p53 and (D) b-actin. (C) is an overexposed version of the
Western blot shown in (B). The Western blot for b-actin is included as
a loading control.2.6. UV irradiation
A549 cells, grown in 6 cm plastic tissue culture dishes, were transfec-
ted, using Lipofectamine 2000, with either pcDNA3 or E1B-AP5-HA-
tag in the same vector. After 24 h the medium was removed and cells
exposed to UVC irradiation (254 nm) for varying times. After additionof medium, cells were incubated for 6 h and then harvested and solu-
bilized in 9 M urea, 50 mM Tris–HCl, pH 7.5 before SDS–PAGE and
Western blotting.
2.7. Antibodies
E1B-AP5 was detected in Western blotting with rat monoclonal
antibodies 4All or 6C5 (used at a dilution of 1:1000) and immuno-
precipitated using a rabbit polyclonal antibody (10 ll); p53 was
detected in Western blots with the mouse monoclonal antibody DO1
(dilution 1:10). p53 was immunoprecipitated with a rabbit polyclonal
antibody (Santa Cruz) (20 ll). HA-tagged E1B-AP5 was detected with
a rat monoclonal antibody (Roche) (dilution 1:1000). p21 was detected
with a rabbit polyclonal antibody (Santa Cruz) (dilution 1:500).3. Results
Although it is now well established that hnRNPs play a ma-
jor role in RNA metabolism it is becoming apparent that a
number of family members also regulate transcription directly
by binding to transcriptional regulators [5–7]. With this in
mind we have considered the possibility that E1B-AP5 may
also form complexes with other proteins involved in transcrip-
tion. Therefore, a possible interaction with the transcription
factor p53 was examined.
Western blots showing levels of expression of E1B-AP5 and
p53 in the cell lines used in this study are shown in Fig. 1A–D.
E1B-AP5 concentrations are similar in all lines but there are
appreciable diﬀerences in p53, with, for example, very high lev-
els in C33A and HT29 cells, where the p53 gene is mutated,
and Ad12HER2, 911 and 293 cells which express AdE1 pro-
teins. Appreciably lower levels of p53 can be seen in A549
and HCT116 cells which express wild-type protein; no p53 is
expressed in H1299 cells (Fig. 1C). Variations in the level of
b-actin are indicative of diﬀerent cell types rather than loading
variations.
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A number of diﬀerent approaches were adopted to the study
of the E1B-AP5/p53 interaction. Initially, cell lysates were
incubated with GST-E1B-AP5 (20 lg) and protein complexes
isolated using glutathione–agarose beads. The quantity of each
lysate used was such that it contained an equivalent amount of
p53. (This was calculated by densitometric scanning of Wes-
tern blots similar to those shown in Fig. 1B and C.) The study
presented in Fig. 2A is based on the use of 10 mg of A549 pro-
tein and equivalent p53-containing quantities from the other
cell lines. Bound proteins were released with glutathione and
identiﬁed by Western blotting (Fig. 2A). It can be seen that
p53 is bound by GST-E1B-AP5 to a comparable extent in all
of the cell lines examined. It was isolated as a binding partner
for E1B-AP5 from tumour cell lines expressing wild type
(A549) and mutant protein (C33A) and from adenovirus trans-
formed cell lines (Ad12E1HER2 cells and Ad5E1911 cells). It
is apparent therefore that interaction of AdE1B55K with p53,
does not preclude the binding of p53 by E1B-AP5 in estab-
lished AdE1-transformed cell lines.
These interactions were conﬁrmed by co-immunoprecipita-
tion. p53 was immuno-precipitated from cell lysates of
MCF7 and Ad12E1HER2 cells using a rabbit polyclonal anti-
body. Co-precipitated E1B-AP5 was identiﬁed by Western
blotting (Fig. 2B). In reciprocal experiments E1B-AP5 was
immunoprecipitated with a rabbit polyclonal antibody. Co-
immunoprecipitating p53 was detected using the monoclonal
antibody D01 in Western blots (Fig. 2C). Although p53 was
co-precipitated with E1B-AP5 it was necessary to use in vitro
translated proteins to conﬁrm direct binding. Therefore,
E1B-AP5 was labelled with [L-a-35S]methionine in in vitro
transcription–translation assays and shown to interact with
GST-p53 (Fig. 3).Fig. 2. E1B-AP5 binds p53 in vitro and in vivo. (A) Cell lysates containing eq
(20 lg). Bound protein was analysed by Western blotting using an antibody
Co-immunoprecipitation of E1B-AP5 with p53. p53 (panel B) or E1B-AP5
After Western blotting samples were analysed for co-immunoprecipitated E13.2. Mapping binding sites on E1B-AP5 and p53
To determine the binding site for p53 on E1B-AP5 frag-
ments of the protein covering the N-terminal region (1–453),
the central region (213–732) and the C-terminal region (395–
856) were translated in vitro in the presence of [L-a-35S]methi-
onine. These 35S labelled polypeptides were then incubated
with GST-p53 in pull-down assays (Fig. 3). p53 bound
strongly to E1B-AP5 and the constituent polypeptide frag-
ments (Fig. 3). Interaction can be seen with the C-terminal
and central regions and to a somewhat lesser extent with the
N-terminal region (Fig. 3). (Densitometric scanning of the
autoradiograph shown in Fig. 3 indicates that 8%, 2%, 9%
and 5% of the input of full length, N-terminal fragment, cen-
tral fragment and C-terminal fragment, respectively, bound
to the GST-p53.) Virtually, no binding of the E1B-AP5 frag-
ments to GST was seen. The C-terminal and central region
polypeptides of E1B-AP5 overlap from amino acids 395–732
and it is possible that these residues encompass a major bind-
ing site for p53. Additional minor binding sites could also be
present.
A second series of pull-down experiments was undertaken in
which polypeptide fragments of p53 (as GST fusions) were
incubated with L-a-35S labelled methionine in vitro translated
E1B-AP5. After binding and SDS–PAGE, it was observed that
E1B-AP5 interacted predominantly with the C-terminal region
of p53 (Fig. 4). Thus 35S labelled E1B-AP5 was bound strongly
by full-length protein and a fragment comprising amino acids
318–393 (the C-terminus). The larger C-terminal polypeptide,
160–393, also interacted with E1B-AP5. We conclude that
the major site of interaction lies C-terminal to amino acid
318, in the regulatory domain which also contains the tetra-
merization/oligomerization domain as well as binding sites
for other proteins such as Ad5E4 orf6 [14]. It is notable thatual amounts of p53 were incubated with GST-E1B-AP5 or GST alone
against p53 (D01). Cell lines used are indicated under the ﬁgure. (B, C)
(panel C) were immunoprecipitated with rabbit polyclonal antibodies.
B-AP5 or p53, respectively. Cell lines used are indicated in each panel.
Fig. 3. Sites of interaction for p53 on E1B-AP5. Polypeptide
fragments of E1B-AP5 were expressed and labelled with [35S]methio-
nine in a wheat germ in vitro transcription/translation mix and
incubated with GST-p53, or GST alone. Bound proteins were
fractionated by SDS–PAGE and detected by ﬂuorography and
autoradiography. The input shown constitutes 10% of the actual input
used in each pull-down experiment. The E1B-AP5 polypeptides used
are shown below the ﬁgure: E1B-AP5 full length, amino acids 1–856;
E1B-AP5 N-terminal region, amino acids 1–453; E1B-AP5 central
region, amino acids 213–732; E1B-AP5 C-terminal region, amino acids
395–856.
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observed – this is the site of interaction with AdE1B55K and
with Mdm2 [15]. Very limited interaction was observed with
a large N-terminal polypeptide (1–205) however.
3.3. The inhibition of p53 transcriptional activity by E1B-AP5
To examine the eﬀects of E1B-AP5 on the transcriptional
activity of p53, luciferase reporter assays were performed. Plas-
mids encoding p53, E1B-AP5 and a luciferase gene down-
stream of multiple copies of a p53 DNA binding motif were
transfected into H1299 (p53 negative) cells. Luciferase activity
was measured after 24 h. Variations in the eﬃciency of trans-
fection were corrected using a control Renilla luciferase
construct as recommended (Promega). It can be seen that
E1B-AP5 was able to inhibit p53 activity in a dose-dependent
manner but was not as eﬀective as the well-characterized inhib-
itor, Ad5E1B55K protein, in the assay (Fig. 5A). To determine
the region of E1B-AP5 responsible for this activity the three
fragments which were used in the binding assays were co-trans-
fected into H1299 cells (Fig. 5B). All three of the polypeptides
inhibited p53 activity to a limited extent although the C-termi-
nal and central fragments were the most potent. These data are
consistent with the results of the binding experiments shown in
Fig. 3. To conﬁrm the biological relevance of these investiga-
tions a luciferase construct with an upstream element identical
to the p53 binding motif of the p21 gene was used in the repor-Fig. 4. The binding site for E1B-AP5 on p53. E1B-AP5 was labelled with [3
incubated with polypeptide fragments of p53 linked to GST (lane 2–12) or GS
detected by ﬂuorography and autoradiography. The dimensions of each p53
full-length p53 constructs were tested (lanes 6 and 9).ter assays. Again, E1B-AP5 inhibited the luciferase activity
(Fig. 5C).
3.4. E1B-AP5 can mediate the activity of p53 following UV
irradiation
To investigate further the relationship between E1B-AP5
and p53 the eﬀect of transfected E1B-AP5 on p53 induction
following UV irradiation was examined. A549 cells were trans-
fected with HA tagged-E1B-AP5 or with pcDNA3 as a control
(Fig. 6). Twenty-four hours post-transfection cells were irradi-
ated with various doses of UVC radiation. Western blotting,
using an antibody against the HA tag, conﬁrmed expression
of the tagged E1B-AP5 protein in transfected cells (Fig. 6A).
Comparable induction of p53 following UV treatment was
seen in cells transfected with E1B-AP5 and the empty vector
(Fig. 6B). Signiﬁcantly, following irradiation the additionally
transfected E1B-AP5 had an inhibitory eﬀect on p53 induction
of p21. Thus, in those cells transfected with pcDNA3 (empty
vector) an increase in p21 expression was observed following
irradiation (Fig. 6C). Reduced induction was observed in cells
transfected with E1B-AP5-HA-tag (Fig. 6C).4. Discussion
E1B-AP5 was ﬁrst isolated as an Ad5E1B55K binding pro-
tein [1]. Sequence determination showed it to be a member of
the hnRNP family with particular similarity to hnRNP-U/
SAF-A and hnRNP-SAF-B. Like other hnRNPs, E1B-AP5
can play a part in RNA metabolsm [1,2]. Studies have
demonstrated that hnRNPsparticipate in various nuclear events
– some of which are closely involved in regulation of transcrip-
tion. This has prompted us to consider the possibility that
E1B-AP5 could function in a comparable manner. Therefore,
we have investigated certain aspects of the relationship be-
tween E1B-AP5 and a well-characterized transcription factor,
p53. Binding of E1B-AP5 to p53 was demonstrated with a
number of approaches. Using pull-down assays it has been
shown that p53 can be isolated with GST-E1B-AP5. Both
wild-type (in the cell lines A549 and HCT116) and mutant
(in the cell line C33A) p53 bound to E1B-AP5 to a similar
extent; furthermore, interaction occurred in the absence or
presence of AdE1B55K protein (in Ad12E1HER2 and Ad5-
HEK293 cells), or SV40T antigen (Cos cells) (Fig. 2A). The
observation that p53, E1B-AP5 and AdE1B55K can all inter-
act with each other suggests that a ternary complex could be5S]methionine using an in vitro transcription/translation mix and was
T alone (lane 1). Bound proteins were fractionated by SDS–PAGE and
polypeptide–GST fusion are shown above the ﬁgure. Two independent
Fig. 5. The eﬀect of E1B-AP5 on p53 transcriptional activity. Plasmids
encoding p53, E1B-AP5 or Ad5 E1B55K protein and a reporter
construct comprising a luciferase gene downstream of either ﬁve copies
of a p53 DNA binding motif or the p53 binding motif for the p21 gene
were transfected into H1299 cells. Luciferase activity was determined
after 24 h. Transfected plasmids are indicated below the ﬁgures. (A)
The eﬀect of increasing concentrations of E1B-AP5 on p53 transcrip-
tional activity; (B) the eﬀects of E1B-AP5 polypeptide fragments on
p53 activity. The dimensions of the E1B-AP5 fragments are: C-t,
amino acids 395–856; M, 213–732; and N-t, 1–453. In panel B, 4 lg of
E1B-AP5 and the E1B-AP5 fragments were used in each transfection.
(C) The eﬀect of E1B-AP5 on the p53-dependent transcription
mediated by the p53 binding motif in the p21 gene. Each experiment
was repeated at least four times.
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dence to support this possibility. However, we suggest that dis-
ruption of the p53-E1B-AP5 complex is not a major role for
the adenovirus E1B protein since similar amounts of p53 couldbe bound by GST-E1B-AP5 in adenovirus E1 containing cells
as in human tumour cells (Fig. 2A).
Using GST fusion proteins and in vitro transcribed and
translated binding proteins the direct interaction of p53 with
E1B-AP5 has been conﬁrmed. Although these proteins may
also form part of a high-molecular weight multi-protein
complex in vivo (our unpublished data) it is clear that there
is a direct association. The binding sites on the two proteins
have been mapped using a combination of in vitro trans-
lated 35S labelled proteins and polypeptide fragments ex-
pressed as GST fusion proteins. A major binding site on
E1B-AP5 for p53 appears to be located in the central region
between amino acids 395 and 732. This overlaps the domain
involved in RNA binding and the binding sites for BRD7
and hPRMT2 [16,17]. It is notable that E1B-AP5 is methyl-
ated on arginine residues in the RGG box (amino acids 611–
685) by HRMT1L1 [16]. This region may encompass the
binding site for p53. It is also possible that methylation
could cause changes in charge and/or conformation thus reg-
ulating binding [16].
Using reporter assays, we have demonstrated that E1B-AP5
is able to repress p53-mediated transcription in a dose-depen-
dent manner although it is appreciably less potent than the
Ad5E1B55K protein [18] which was included as a control in
Fig. 5. Whilst the major site of interaction for p53 appears
to reside in the central region all three fragments (N-terminal,
C-terminal and central region) of E1B-AP5 are capable of
inhibiting p53 activity to some extent, although the C-terminal
region is most eﬀective.
The site of interaction for E1B-AP5 on p53 is located to-
wards the C-terminus of the protein. This binding region prob-
ably overlaps the regulatory/tetramerization domain and the
binding sites for a number of proteins involved in replication
and repair, such as TFIIH components [19] and CSB [20].
Interestingly, two other viral proteins interact with the C-ter-
minal domain of p53. It has been shown that Ad5E4 orf 6
[14] and the EBV BZLF1-encoded ZEBRA protein [20] bind
to p53. Ad5E4orf6, like E1B-AP5, is able to inhibit p53 tran-
scriptional activity. Whether this implies a similar binding site
for E4orf6 and E1B-AP5 is not yet clear.
In an attempt to understand the biological signiﬁcance of the
interaction of p53 and E1B-AP5, its eﬀect on the cellular re-
sponse to UV irradiation has been assessed. Overexpression
of E1B-AP5, following transfection, did not alter p53 induc-
tion (Fig. 6B) nor did it reduce phosphorylation of the protein
on serine 15 (data not shown). However, downstream events
such as an increase in p21 expression were appreciably inhib-
ited. Some inhibition of Mdm2 induction was also observed
(data not shown). This might, simplistically, be attributed to
an inhibition of p53 transcriptional activity by the direct bind-
ing of p53 by E1B-AP5 as seen in Fig. 5. Whether E1B-AP5
could play a part in regulating p53 activity in vivo is not clear
but it would be of considerable signiﬁcance if a protein directly
involved in RNA metabolism could also have a role in modu-
lating the action of a protein whose mutation is so common in
human cancers.
In summary, we have established that the hnRNP family
member E1B-AP5 can interact with p53, controlling its tran-
scriptional activity. This provides further support for the con-
tention [17] that E1B-AP5 is a transcription co-factor linking
transcriptional regulation, chromatin remodelling and mRNA
processing.
Fig. 6. Exogeneous E1B-AP5 inhibits the p53-mediated cellular response to UV irradiation. A549 cells were transfected with pcDNA3 or the same
vector expressing E1B-AP5-HA-tag. After 24 h, cells were exposed to various doses of UVC irradiation and harvested after 6 h. Protein expression
was analysed by Western blotting. (A) E1B-AP5-HA-tag expression. Lane 1, untransfected cells; lanes 2–7, transfected cells exposed to UV
irradiation; (B) p53 expression in A549 cells transfected with E1B-AP5-HA-tag and exposed to UV, lane 1, untransfected cells; lanes 2–7 transfected
with E1B-AP5-HA-tag. Lanes 8–13, transfected with pcDNA3. (C) Expression of p21 in A549 cells transfected with E1B-AP5-HA-tag and exposed
to UV irradiation. Lane 1, untransfected cells; lanes 2–7, transfected with E1B-AP5-HAtag; lanes 8–13, transfected with pcDNA3. In each panel, the
dose of UV radiation is indicated below each blot. Western blots for b-actin are included in panels B and C as loading controls.
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